Cardiovascular pharmacology, like other biological disciplines, is not free from controversy. Part of this, which might well be avoidable, is the result of such as the following: free application to the intact animal of results obtained on isolated organs and tissues; underestimation of species differ ences as well as the effect of anesthetics; insufficient appreciation of the influ ence of dosage and method of administration of drugs. It is not uncommon to observe one effect at low concentrations and an entirely opposite effect with higher dosages even on the same segment of the cardiovascular system. Mellander (1), for example, found that intravenous epinephrine (E) infusion at the rate of OAl'g/kg/min resulted in marked dilatation of the "resistance"